CertaPeptides has built its current research catalog around a simple idea: researchers should be able to move from a broad research area to an individual compound, identify its supplied format, and then check the documentation associated with that product without treating every listing as interchangeable. The catalog currently spans research peptides, peptide blends, bioregulators, metabolic and cellular-aging compounds, research kits, and laboratory accessories, arranged into research-oriented categories rather than one undifferentiated product list.
All CertaPeptides research compounds discussed here are intended strictly for controlled in-vitro or laboratory research by qualified researchers. They are not intended for human or veterinary use, consumption, administration, diagnosis, treatment, prevention, clinical application, supplementation, cosmetic use, or personal experimentation.
Researchers exploring the catalog can access the CertaPeptides research catalog with LOOT30 and use promo code LOOT30 for up to 30% off. The code does not change the scientific questions that should guide procurement: what compound is being studied, which category it belongs to, what material or format is being supplied, what documentation accompanies it, and whether the available analytical information is appropriate for the intended laboratory work.
Understanding that structure makes the catalog substantially easier to navigate.
The fastest way to understand the CertaPeptides catalog
At the time of this review, the main CertaPeptides shop displays 68 products, including 62 vial-form products and six accessories. Those products are distributed across categories such as bioregulators, copper and mitochondrial compounds, cyclic and neuropeptide compounds, endocrine and hormone research peptides, GLP-1 and incretin peptides, gonadotropic peptides, growth-factor research peptides, tissue-healing and regeneration compounds, metabolic and cellular-aging compounds, laboratory consumables, and research kits.
That organization is important because a catalog category is not merely a menu label. It gives the researcher an initial scientific context.
A researcher interested in mitochondrial signaling, for example, can begin in the copper and mitochondrial section rather than scanning dozens of unrelated names. Someone examining incretin-receptor systems can narrow attention to the GLP-1 and incretin category. A laboratory looking primarily for supporting supplies does not need to search through compound listings because consumables are separated into their own category.
The result is a catalog that can be approached in layers:
- identify the research area;
- narrow to the relevant category;
- distinguish individual compounds from blends, kits, and accessories;
- open the specific product page;
- examine the product identity and supplied format;
- review the associated documentation or COA information;
- only then make a procurement decision appropriate to the laboratory's study requirements.
This category-first approach is more reliable than choosing products merely because their names are familiar.
Category labels are navigation tools, not substitutes for product identity
The most important distinction when browsing any research-compound catalog is that a category describes how a supplier has organized the inventory. It does not replace the molecular identity of the individual compound.
CertaPeptides currently shows categories including the following:
| Catalog area | What it helps a researcher locate |
|---|---|
| Bioregulator research peptides | Compounds grouped under bioregulator-oriented research |
| Copper and mitochondrial research peptides | Copper-associated and mitochondrial research compounds |
| Cyclic and neuropeptide research compounds | Cyclic peptides and compounds studied in neuropeptide-related research |
| Dermatological and skin research compounds | Materials grouped around skin and tissue research |
| Endocrine and hormone research peptides | Peptides associated with endocrine or hormone-signaling research |
| GLP-1 and incretin research peptides | Compounds studied in incretin and related metabolic receptor systems |
| Gonadotropic research peptides | Materials associated with gonadotropic signaling research |
| Growth factor research peptides | Compounds grouped around growth-factor-related research |
| Laboratory consumables and reconstitution supplies | Non-compound laboratory accessories and supplies |
| Melanocortin and pigment research peptides | Compounds associated with melanocortin-system research |
| Metabolic and cellular-aging research compounds | Materials grouped around metabolism and cellular-aging research |
| Research kits and multi-compound sets | Bundled research materials |
| Thymic research peptides | Peptides associated with thymic research |
| Tissue healing and regeneration research compounds | Compounds grouped around tissue-remodeling and regeneration research |
The live catalog presently shows these categories with separate product counts, making it possible to narrow the inventory before evaluating individual listings.
Researchers should still read the actual product page after choosing a category. Two compounds placed in the same category may have completely different sequences, molecular structures, receptor interactions, experimental histories, analytical requirements, or limitations.
Category membership answers the question “Where should I start looking?”
It does not answer “What exactly is this material?”
That second question belongs to the individual product record and its documentation.
Single compounds form the core of the catalog
A large portion of the CertaPeptides catalog consists of individual research compounds supplied in vial form. The current shop includes examples such as BPC-157, TB-500, GHK-Cu, MOTS-c, Ipamorelin, SS-31, Selank, Semax, Epitalon, KPV, Thymosin Alpha-1, DSIP and KissPeptin-10, among many others.
This is the simplest catalog structure conceptually: one named compound corresponds to one product listing, although some products may have more than one available quantity or presentation.
For researchers, individual-compound pages are generally where the most important identity questions begin:
- What compound does the product name actually represent?
- Is the material a peptide, peptide fragment, analog, coenzyme, or another research compound?
- What quantity or concentration is listed?
- What physical form is supplied?
- What specification is stated?
- Is there a corresponding certificate or analytical report?
- Does the documentation identify a lot or report code?
- Is the listed compound being described accurately rather than through a colloquial synonym?
Those questions matter because familiar shorthand can conceal meaningful distinctions.
TB-500 provides a useful example. The current CertaPeptides catalog specifically distinguishes TB-500 from full-length Thymosin Beta-4 rather than treating the terms as exact synonyms. That kind of identity distinction is more useful to a laboratory reader than a broad category label alone.
Likewise, products such as GHK-Cu or MOTS-c appear within the copper and mitochondrial category, but their molecular identities and research contexts are very different. The category helps locate them; the individual record explains what each product actually is.
For researchers comparing suppliers, this is a useful habit to carry beyond CertaPeptides: compare individual identities and documentation, not just matching menu categories.
Blends should be read differently from single-compound listings
The catalog also contains multi-compound blends. Examples presently visible include CJC-1295 + Ipamorelin, Semax + Selank, BPC-157 + TB-500, and multi-component products such as Glow Blend and Klow Blend.
A blend is fundamentally different from a single-compound vial because the product identity depends on more than one constituent.
A laboratory evaluating a blend should therefore ask at least three additional questions.
First, which compounds are included?
A blend name may provide an immediate answer in some cases, such as CJC-1295 + Ipamorelin, while a branded blend name requires the constituent list to be read carefully.
Second, what is the stated composition?
A total vial quantity alone does not necessarily tell a researcher how that quantity is distributed among components. When the listing provides individual component amounts or ratios, those details become part of the product identity.
Third, what exactly does the analytical documentation measure?
For a single compound, purity analysis may be relatively straightforward to interpret conceptually: the laboratory is examining one principal analyte against the analytical method used.
A multi-component product introduces a more complicated question. Does the report confirm identity? Purity? Content? Relative component amounts? More than one analytical endpoint?
CertaPeptides' current COA presentation provides examples where multi-compound products are described using content-assay or blend-verification information rather than forcing every product into a single identical analytical field.
That is an important distinction for research procurement.
A researcher should not look at the word “COA” and assume that every certificate answers the same question.
Research kits create another catalog layer
Research kits and bundles are another distinct product type.
The live catalog, for example, includes a Retatrutide Laboratory Reconstitution Bundle alongside individual Retatrutide listings. It also lists a Peptide Mixing Kit among laboratory-support products.
These should not be confused with individual research-compound listings.
A kit is a collection.
That means researchers should evaluate it at two levels:
The compound level: What research compound, if any, is included?
The kit level: What additional laboratory components are bundled with it?
This distinction sounds obvious, but it becomes important when comparing catalog prices or documentation. An individual vial and a kit containing that vial plus supporting supplies are not equivalent products simply because both appear in a search for the same compound name.
The catalog structure therefore allows at least four materially different product types to coexist:
- individual research compounds;
- multi-compound blends;
- research kits or bundled sets;
- laboratory accessories and consumables.
Recognizing the product type before comparing listings prevents many avoidable mistakes.
Laboratory accessories belong to the catalog, but not to the peptide taxonomy
CertaPeptides separates laboratory consumables and supporting products from research compounds.
The current catalog includes items such as bacteriostatic water, syringes, and mixing-related supplies. The shop's format filter separately identifies 62 vial products and six accessories, reinforcing the distinction between research compounds and supporting laboratory items.
This matters because accessory pages should not be interpreted through exactly the same documentation framework used for peptide compounds.
The questions are different.
For a peptide, a researcher may focus heavily on molecular identity, purity and content testing.
For a sterile laboratory supply, relevant questions may concern the material specification, sterility, packaging, size, compatibility with laboratory procedures, or other product-specific characteristics.
A well-organized research catalog should make those differences visible rather than forcing compounds and supplies into one conceptual category.
Product format is the second major navigation layer
Once researchers understand categories, the next useful distinction is format.
The current CertaPeptides shop exposes a product-form filter in addition to category filters. At present, the primary visible split is between vial-form products and accessories.
Within the actual product descriptions, however, more specific distinctions appear.
Many research compounds are described as lyophilized material in sealed vials.
Kits combine multiple physical components.
Accessories are sold as their own packaged laboratory products.
Individual products may also appear in multiple stated quantities.
This means that the word format can refer to several related but different characteristics:
Physical presentation: vial, accessory, kit.
Material state: for many research compounds, lyophilized material.
Quantity: the stated amount of material associated with the listing.
Composition: single compound versus multi-component blend.
A researcher should avoid collapsing those characteristics into one.
For example, two products can both be supplied as lyophilized material in sealed vials while representing completely different compounds. Two listings can have the same named compound but different quantities. Two products can share the same total vial quantity while one is a single compound and the other a blend.
The format field therefore helps narrow procurement, but molecular identity and documentation remain essential.
How product naming should be read
Product names in research catalogs tend to combine several kinds of information.
A name can indicate:
- molecular identity;
- a commonly used abbreviation;
- an analog or fragment;
- a combination of two or more compounds;
- a specific variant;
- a stated quantity;
- a bundled format.
That is why names should be read literally rather than approximately.
A researcher familiar with a broad compound family should not assume that every variant is interchangeable.
For example, the current catalog separately identifies CJC-1295 Without DAC and combination products containing CJC-1295.
Similarly, an individual compound listing and a blend containing that same compound are separate research materials.
The same principle applies to quantities. A number included in a product name or option should be understood as part of that particular listing, not as a universal specification for the molecule.
An earlier overview of CertaPeptides single compounds, blends, kits and accessories provides another useful way to approach this distinction: product naming works best when researchers separate the molecular name from the packaging, combination and quantity information around it.
The current catalog organization makes that reading process easier because single compounds, blends, kits and accessories appear as distinct products rather than being treated as one product family.
Why documentation should be treated as a separate catalog layer
Perhaps the most important feature of the current CertaPeptides structure is that documentation is not limited to a small text note beneath individual products.
CertaPeptides maintains a separate Certificates of Analysis area.
At the time checked for this article, the COA vault reports 64 entries, including 30 Janoshik reports and additional product lines covered by supplier specifications. The page explicitly distinguishes its supplier-specification tier from independently verified Janoshik reports and explains that product cards may move from supplier-spec coverage to independent verification as additional reports are published.
That distinction deserves attention.
A supplier specification and an independent laboratory report are not the same kind of evidence.
A supplier specification tells the researcher what specification the product is supplied against.
An independent analytical report provides results generated through an external analytical process for the reported sample or lot.
Both may be useful, but they answer different questions.
The catalog therefore has two parallel structures:
Commercial/product structure: categories, products, forms, quantities and kits.
Documentation structure: specifications, certificates, report codes, test dates, measured values and external verification where available.
Researchers gain a much clearer picture by examining both.
What a COA can tell you—and what it cannot
“COA” is often used loosely in research-product discussions, but a certificate should be read as a specific document.
A researcher should ask:
- Which product or sample does the report identify?
- Is there a lot, batch or report code?
- What test was performed?
- Which laboratory performed it?
- What date appears on the report?
- Is purity measured?
- Is content or quantity measured?
- Are additional analytical endpoints reported?
- Is there an external verification destination?
- Does the document correspond to the product being evaluated?
CertaPeptides' current COA vault exposes fields such as product name, test type, report code, test date, laboratory and measured results for independently tested entries.
That structure is more useful than treating a certificate as a generic badge.
A document can support a specific analytical claim. It does not automatically answer every possible question about a compound.
For example, a purity result does not by itself establish every aspect of identity, concentration, sterility, stability, biological activity or suitability for a particular experimental design.
Likewise, an independent report for one tested sample should not automatically be extrapolated to every batch ever sold under the same product name.
Researchers should connect the scope of the analytical document to the scope of the conclusion they draw from it.
Supplier specification versus independent verification
CertaPeptides currently states that every shipped product line is covered by its supplier-specification tier, while selected products or lots have independent third-party reports available through the COA vault.
This creates a useful documentation hierarchy.
A simplified way to read it is:
Tier 1: supplier specification
This defines the supplier's stated batch specification for the product.
Tier 2: independent report
This adds third-party analytical evidence for the tested sample or lot.
The difference matters because supplier claims and independent measurements should not be described as identical evidence.
CertaPeptides' homepage also surfaces independently tested examples and links those reports to the issuing laboratory for verification.
For researchers comparing products, the practical question is therefore not merely “Does this product show a COA badge?”
A better question is:
“What kind of documentation is available for this exact product or lot, what was measured, and who generated the result?”
That approach is more scientifically useful and remains applicable to supplier evaluation generally.
For a deeper documentation-focused perspective, the previously published guide to reading a peptide COA can be used alongside the catalog itself.
Catalog organization helps separate science from marketing
Research compounds frequently become known through popular shorthand, online discussions or heavily simplified descriptions.
A structured catalog provides an opportunity to reverse that process.
Instead of starting with a claim about what a compound supposedly “does,” researchers can start with:
- its identity;
- its category;
- its supplied form;
- the available documentation;
- the published research literature;
- the limitations of that evidence.
That ordering is especially important for compounds that attract public attention because of preclinical or emerging research.
CertaPeptides' FAQ currently states that its peptides are supplied strictly for in-vitro laboratory research and are not intended for human consumption, veterinary use or clinical application.
That boundary should shape how the catalog is read.
A product category such as “tissue healing and regeneration research compounds” describes a research grouping. It is not a treatment recommendation.
A category such as “metabolic and cellular-aging research compounds” is not permission to translate experimental findings into personal-use claims.
A GLP-1 or incretin category is a navigation tool for relevant research compounds, not clinical prescribing information.
The catalog is most useful when it is treated as an inventory for laboratory procurement rather than as a collection of health outcomes.
How to navigate from a research question to the right catalog section
Suppose a laboratory begins with a broad scientific question involving mitochondrial signaling.
The researcher could start in the Copper and Mitochondrial Research Peptides category. The current catalog places GHK-Cu, MOTS-c and SS-31 among the products visible in that area.
That does not mean those compounds are interchangeable.
It means they share enough research context for the supplier to group them together.
The next step is to open the individual product record and examine the molecular description and documentation.
A laboratory interested in neuropeptide-related research would instead begin with the Cyclic and Neuropeptide Research Compounds category, where compounds such as Selank, Semax and DSIP appear.
A study involving tissue-remodeling research could begin in the Tissue Healing and Regeneration Research Compounds area.
An endocrine-focused project could begin in the Endocrine and Hormone Research Peptides section.
This is the central benefit of the category system: it reduces navigation complexity without pretending that all members of a category have the same mechanisms or evidence base.
The earlier CertaPeptides category and format navigation guide is particularly relevant for readers who want a broader walkthrough of the category-first approach.
Broad catalog pages and individual product pages serve different purposes
A catalog page is good for comparison.
A product page is good for specificity.
Researchers should use both.
The broad CertaPeptides shop currently allows filtering by category, product form and sort order, while also providing a search field for locating individual compounds.
That makes the shop useful for questions such as:
- What categories are represented?
- Which compounds appear within a category?
- Are accessories separated from research compounds?
- Are kits available?
- Does a particular product name appear in the inventory?
- Are multiple forms or quantities shown?
An individual product record becomes more useful when the question changes to:
- What exactly is this compound?
- Which variant is being sold?
- What quantity is listed?
- What research-use statement accompanies it?
- What specification is stated?
- Is documentation linked?
Researchers who rely only on the broad catalog risk missing product-specific distinctions.
Researchers who land directly on one product page risk missing comparable formats or adjacent categories.
The most efficient workflow moves between both views.
The catalog and COA vault should be read together
A particularly useful practice is to treat the shop and COA vault as two halves of one procurement record.
The shop answers:
What is currently listed?
The documentation area answers:
What supporting specification or analytical record is available?
That distinction prevents a common mistake in supplier comparisons: treating the commercial listing itself as analytical evidence.
Product descriptions can provide useful identity and contextual information, but analytical claims should be traced back to the relevant report wherever possible.
CertaPeptides' current homepage reinforces this distinction by linking independently verified results to external Janoshik reports and directing readers to the broader COA vault.
A researcher reviewing a product can therefore move in a sensible sequence:
catalog → product page → COA vault → underlying analytical report
That is much stronger than stopping at a percentage printed on a product card.
Purity percentage should never be read in isolation
Purity percentages are among the most visible figures in peptide catalogs, and therefore among the easiest to overinterpret.
A purity figure becomes more meaningful when the researcher knows:
- the analytical method;
- the sample tested;
- the report date;
- the laboratory;
- the report identifier;
- whether content was measured separately;
- whether additional tests were performed;
- whether the document can be independently verified.
The current CertaPeptides COA vault includes independently tested entries where purity and measured content are displayed separately.
That separation is important.
Purity and quantity are different analytical questions.
A sample can have high chromatographic purity without the container necessarily holding exactly the nominal quantity stated on the label. Conversely, knowing measured content does not replace purity analysis.
This is why researchers should resist reducing supplier evaluation to a single percentage.
Documentation is strongest when its individual measurements are read according to what they actually represent.
Catalog size is less important than catalog readability
A supplier can advertise dozens or hundreds of products and still provide a difficult research-procurement experience.
Catalog size becomes useful only when researchers can identify what they are looking at.
The current CertaPeptides structure attempts to do this by combining:
- research-area categories;
- product-form filtering;
- search;
- individual product pages;
- separate blend and kit listings;
- laboratory-accessory listings;
- COA indicators;
- a dedicated documentation vault.
The live shop presently lists 68 products across those structures.
For a laboratory, however, the important number is not 68.
The important question is how quickly the relevant two or three products can be isolated and evaluated.
A catalog is functioning well when it reduces ambiguity rather than simply maximizing inventory.
Availability should always be checked at the current product page
Research catalogs change.
Products can be added, removed, renamed, reorganized or temporarily unavailable. Quantities can change. Documentation can be updated as newer lots are tested.
For that reason, researchers should treat articles about a catalog as navigation aids rather than permanent inventory records.
The current category structure and product count reported here reflect the live catalog checked for this article. The live shop remains the appropriate source for current availability.
The previously published CertaPeptides product-availability overview is useful background, but the current catalog should take priority whenever the two differ.
This principle also applies to analytical documentation.
A supplier may publish newer reports after an article is written. Researchers should therefore open the current COA record rather than relying solely on a screenshot, quotation or older summary.
How shipping fits into catalog evaluation
Shipping is not part of molecular identity, but it can matter to procurement.
CertaPeptides currently states that it ships across all 27 EU member states plus Switzerland, the United Kingdom, Iceland, Israel and Serbia. Its current shipping page identifies different carriers and delivery structures depending on destination.
That information should remain conceptually separate from the scientific catalog.
A product being listed does not establish that import, possession, customs clearance or a specific research use is lawful in every destination.
Likewise, shipping availability is not evidence of scientific quality.
Researchers should therefore keep three evaluations separate:
Scientific evaluation: Is the compound appropriate to the experimental question?
Documentation evaluation: Is the identity/specification/testing information adequate?
Procurement evaluation: Can the laboratory lawfully and practically obtain the material under applicable institutional and destination-country requirements?
Combining those questions into a single idea of whether a supplier is “good” loses useful detail.
A documentation-first catalog workflow
For laboratories that need a repeatable process, the current catalog can be approached in a simple documentation-first sequence.
Start with the research question, not the product name.
Identify the biological pathway, receptor, molecular target, experimental model or analytical objective being studied.
Then identify the catalog category that most closely matches that question.
From the category, create a small list of potentially relevant compounds.
Open each individual product record and confirm exact identity, variant, quantity and composition.
Distinguish single compounds from blends.
If the product is a kit, identify the individual contents rather than treating the kit name as a molecular identity.
Check whether the item is a research compound or laboratory accessory.
Then move to the COA vault and inspect the documentation associated with the product.
Identify whether the available record is a supplier specification or an independent analytical report.
If an independent report exists, examine the underlying report rather than relying only on the catalog badge.
Finally, compare that information with the needs of the experimental design and the laboratory's own procurement standards.
This sequence helps prevent marketing familiarity from replacing scientific relevance.
How CertaPeptides' current organization compares with a flat product list
A flat catalog might present dozens of products alphabetically.
That approach is efficient only when the researcher already knows the exact product name.
CertaPeptides' current category-based organization supports a second type of user: someone who knows the research area but has not yet narrowed the project to one compound.
That is especially helpful in large research areas.
The Endocrine and Hormone Research Peptides category presently contains more listings than several smaller categories, while areas such as Bioregulator Research Peptides contain a much narrower inventory.
The category system therefore acts as an intermediate level between “all products” and “one specific product.”
This three-level structure can be summarized as:
Catalog → category → product → documentation
That is the organizing logic behind the current site.
A related CertaPeptides catalog structure explainer covering peptides, blends, bioregulators, kits and supplies provides additional context on how those inventory types fit together.
Frequently asked questions
How many products are currently listed in the CertaPeptides catalog?
The live shop displayed 68 products when checked for this article, including 62 vial-form products and six accessories. Because inventories can change, the current catalog should be checked for the latest count.
What are the main CertaPeptides product categories?
Current categories include bioregulators, copper and mitochondrial research peptides, cyclic and neuropeptide compounds, dermatological and skin research compounds, endocrine and hormone peptides, GLP-1 and incretin peptides, gonadotropic peptides, growth-factor peptides, laboratory consumables, melanocortin and pigment peptides, metabolic and cellular-aging compounds, research kits, thymic peptides, and tissue-healing and regeneration compounds.
Are all CertaPeptides products individual peptides?
No. The catalog contains individual research compounds, multi-compound blends, kits and laboratory accessories. Researchers should identify the product type before comparing listings.
What is the difference between a single compound and a blend?
A single-compound listing represents one named research material. A blend contains two or more specified components. Blend documentation should therefore be read with attention to individual constituents, ratios or amounts and the analytical endpoints used to characterize the mixture.
Does CertaPeptides publish COAs?
CertaPeptides currently maintains a dedicated certificate area. At the time checked, it displayed 64 entries, including 30 independent Janoshik reports plus additional product lines covered by supplier specifications.
Does every COA represent independent third-party testing?
No. The current CertaPeptides documentation system explicitly distinguishes supplier-specification coverage from independent Janoshik testing. Researchers should check which type applies to the product or lot being evaluated.
Is a purity percentage enough to evaluate a peptide?
No. Purity is one analytical measurement. Researchers should also consider sample identity, report date, laboratory, report code, measured content when available, method and other relevant analytical endpoints.
Are CertaPeptides products intended for human use?
No. CertaPeptides currently states that its products are for in-vitro research and laboratory use and are not intended for human consumption, veterinary use or clinical application.
Does being listed in a research category mean a compound has a proven human benefit?
No. A catalog category is a navigation and research-classification device. It does not establish clinical efficacy or justify personal use.
Where should a researcher begin if the exact product name is unknown?
Start with the relevant research category, compare the products within that category, then open individual product pages and documentation before narrowing the selection.
Where should a researcher begin if the exact compound is already known?
Use the catalog search to locate the product directly, confirm the correct variant and quantity, and then review its documentation or corresponding COA information.
Should older catalog articles be used to confirm current availability?
They can provide useful context, but current product availability and documentation should be checked against the live catalog because inventories and analytical records can change.
Final perspective: read the catalog as a research information system
The most useful way to approach CertaPeptides is not as a long list of peptide names.
It is better understood as several connected layers.
The category layer narrows the research domain.
The product layer identifies the individual compound, blend, kit or accessory.
The format layer explains how the material is presented.
The documentation layer provides supplier specifications and, for selected products or lots, independent analytical reports.
The policy and shipping layer covers procurement conditions separately from scientific identity.
Keeping those layers distinct makes the catalog easier to navigate and produces better research-procurement questions.
Instead of asking only whether a supplier carries BPC-157, MOTS-c, GHK-Cu, Retatrutide, Semax or another familiar name, a documentation-focused researcher can ask:
What exact product is listed?
Which category is it in?
Is it a single compound or a blend?
Which quantity and format are being supplied?
What documentation applies?
Is the available record a supplier specification or independent report?
What did the analytical test actually measure?
Does that evidence match the requirements of the intended laboratory experiment?
Those questions are far more useful than choosing a product based on popularity or a single headline purity number.
Qualified researchers who want to explore the current inventory can use the CertaPeptides catalog through the LOOT30 research link and enter LOOT30 for up to 30% off.
All products remain strictly for controlled in-vitro and laboratory research by qualified researchers and are not for human or veterinary use, consumption, administration, diagnosis, treatment, clinical application, supplementation, cosmetic use or personal experimentation.
Top comments (0)